Kathleen Maxian, the president of the Western New York Ovarian Cancer Project, has been elected by the National Cancer Institute (NCI) to serve on its Gynecologic Cancer Steering Committee. She is one of two patient advocates on the committee, which includes NCI researchers from across the country.
The committee’s work focuses on research cooperation, priorities and design. Maxian also serves on Roswell Park Cancer Institute’s $11 million Specialized Programs of Research Excellence.
As president of the Ovarian Cancer Project, she works with women and families on cancer detection and treatment strategies, and has fought to prevent biotech companies from holding patents on genes. For more info, visit wnyovariancancerproject.com.